Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14

被引:193
作者
Damian, F
Blaton, N
Naesens, L
Balzarini, J
Kinget, R
Augustijns, P
Van den Mooter, G
机构
[1] Katholieke Univ Leuven, Lab Farmacotechnol & Biofarm, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Lab Analyt Chem & Med Fysicochem, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
UC-781; solid dispersions; DSC; X-ray diffraction; FT-IR spectroscopy; dissolution; PEG; 6000; Gelucire; 44/14;
D O I
10.1016/S0928-0987(00)00084-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to prepare and characterize solid dispersions of the antiviral thiocarboxanilide UC-781 with PEG 6000 and Gelucire 44/14 with the intention of improving its dissolution properties. The solid dispersions were prepared by the fusion method. Evaluation of the properties of the dispersions was performed using dissolution studies, differential scanning calorimetry, Fourier-transform infrared spectroscopy and X-ray powder diffraction. To investigate the possible formation of solid solutions of the drug in the carriers, the lattice spacings [d] of PEG 6000 and Gelucire 44/14 were determined in different concentrations of UC-781. The results obtained showed that the rate of dissolution of UC-781 was considerably improved when formulated in solid dispersions with PEG 6000 and Gelucire 44/14 as compared to pure UC-781. From the phase diagrams of PEG 6000 and Gelucire 44/14 it could be noted that up to approximately 25% w/w of the drug was dissolved in the liquid phase in the case of PEG 6000 and Gelucire 44/14. The data from the X-ray diffraction showed that the drug was still detectable in the solid state below a concentration of 5% w/w in the presence of PEG 6000 and Gelucire 44/14, while no significant changes in the lattice spacings of PEG 6000 or Gelucire 44/14 were observed. Therefore, the possibility of UC-781 to form solid solutions with the carriers under investigation was ruled out. The results from infrared spectroscopy together with those from X-ray diffraction and differential scanning calorimetry showed the absence of well-defined drug-polymer interactions. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:311 / 322
页数:12
相关论文
共 22 条
[1]   Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent [J].
Balzarini, J ;
Naesens, L ;
Verbeken, E ;
Laga, M ;
Van Damme, L ;
Parniak, M ;
Van Mellaert, L ;
Anné, J ;
De Clercq, E .
AIDS, 1998, 12 (10) :1129-1138
[2]   The thiocarboxanilides UC-10 and UC-781 have an additive inhibitory effect against human immunodeficiency virus type 1 reverse transcriptase and replication in cell culture when combined with Other antiretroviral drugs [J].
Balzarini, J ;
DeClercq, E .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (03) :197-204
[3]   Identification of novel thiocarboxanilide derivatives that suppress a variety of drug-resistant mutant human immunodeficiency virus type 1 strains at a potency similar to that for wild-type virus [J].
Balzarini, J ;
Brouwer, WG ;
Dao, DC ;
Osika, EM ;
DeClercq, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) :1454-1466
[4]   The thiocarboxanilide nonnucleoside UC781 is a tight-binding inhibitor of HIV-1 reverse transcriptase [J].
Barnard, J ;
Borkow, G ;
Parniak, MA .
BIOCHEMISTRY, 1997, 36 (25) :7786-7792
[5]   Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: Retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase [J].
Borkow, G ;
Barnard, J ;
Nguyen, TM ;
Belmonte, A ;
Wainberg, MA ;
Parniak, MA .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3023-3030
[6]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1281-+
[7]   CHARACTERIZATION OF POLYETHYLENE GLYCOLS USING DIFFERENTIAL SCANNING CALORIMETRY [J].
CRAIG, DQM ;
NEWTON, JM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 74 (01) :33-41
[8]  
CRAIG DQM, 1996, B TECHNIQUE GATTEFOS, V89, P39
[9]   PREFORMULATION STUDIES ON SOLID DISPERSIONS CONTAINING TRIAMTERENE OR TEMAZEPAM IN POLYETHYLENE GLYCOLS OR GELUCIRE 44 14 FOR LIQUID FILLING OF HARD GELATIN CAPSULES [J].
DORDUNOO, SK ;
FORD, JL ;
RUBINSTEIN, MH .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (12) :1685-1713
[10]   Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation [J].
El-Zein, H ;
Riad, L ;
El-Bary, AA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 168 (02) :209-220